GASTRICHIP is a prospective , open , randomized multicenter phase III clinical study with two arms that aims to evaluate the effects of hyperthermic intraperitoneal chemotherapy with oxaliplatin on patients with gastric cancer involving the serosa and/or lymph node involvement and/or with positive cytology at peritoneal washing , treated with perioperative systemic chemotherapy and D1-D2 curative gastrectomy .